Cargando…
Pathogenesis-based preexposure prophylaxis associated with a low risk of SARS-CoV-2 infection in healthcare workers at a designated COVID-19 hospital: a pilot study
BACKGROUND: At present, no agents are known to be effective at preventing COVID-19. Based on current knowledge of the pathogenesis of this disease, we suggest that SARS-CoV-2 infection might be attenuated by directly maintaining innate pulmonary redox, metabolic and dilation functions using well-tol...
Autores principales: | Dubina, Michael V., Gomonova, Veronika V., Taraskina, Anastasia E., Vasilyeva, Natalia V., Sayganov, Sergey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182762/ https://www.ncbi.nlm.nih.gov/pubmed/34098889 http://dx.doi.org/10.1186/s12879-021-06241-1 |
Ejemplares similares
-
Statistical issues in trials of preexposure prophylaxis
por: Dunn, David T., et al.
Publicado: (2016) -
The European preexposure prophylaxis revolution
por: Cairns, Gus, et al.
Publicado: (2016) -
Eligibility for HIV Preexposure Prophylaxis, Intention to Use Preexposure Prophylaxis, and Informal Use of Preexposure Prophylaxis Among Men Who Have Sex With Men in Amsterdam, the Netherlands
por: Hulstein, Sebastiaan H., et al.
Publicado: (2021) -
Non-immune Prophylaxis Against COVID-19 by Targeting Tolerance for Angiotensin II-Triggered SARS-CoV-2 Pathogenesis
por: Dubina, Michael V.
Publicado: (2022) -
The use of preexposure treatments for HIV prophylaxis
por: Majid, Adrian, et al.
Publicado: (2012)